On Apr. 25, 2019, researchers at the University of Georgia announced they had successfully discovered a single-dose vaccine that provides complete protection against the Crimean-Congo Hemorrhagic Fever, or CCHF, virus in mice, a disease that poses a public health risk and has the potential to cause a major epidemic. Results of the study were published in Emerging Microbes and Infections.

CCHF is acquired through bites from infected ticks of the genus Hyalomma and is also spread by contact with infected animals, such as goats and sheep, or handling infected animal tissue during slaughter.